Takeda FY17 Earnings - First Glance
Takeda Pharmaceutical Co Ltd (4502 JP) reported FY17 results on May 14, 2018 As anticipated, Entyvio (YoY 35.9% to ¥196.6b), Takecab (YoY 61.7% to...
271 Views
Takeda/Shire I : On Drug Deals and Deckchairs
What was rumored, approached, rejected, re-offered and rejected twice more, then agreed.... is now official. Takeda Pharmaceutical Co Ltd (4502 JP)...
748 Views
Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal
Takeda Pharmaceutical Co Ltd (4502 JP) acquiring Shire PLC (SHP LN) is the biggest overseas acquisition ever by a Japanese drugmaker – we continue...
417 Views
Maintaining Our FVE for Shire and Takeda During Extended Offer Period
We’re not making any changes to our fair value estimates for Shire PLC (SHP LN) (GBP 48.90 per share/$205 per ADR) or Takeda Pharmaceutical Co Ltd...
274 Views
No Deal Is a Big Deal for Takeda
Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 24, 2018 proposal of £49 / share (~$206 / ADS), values Shire PLC (SHP LN) at ~$64b, its...
305 Views